GlaxoSmithKline Pakistan Limited (GLAXO) announced the financial results for the year ended December 31, 2019 in which the company declared the Profit After Tax worth Rs. 3.04 Bn that is decreased by 6% annually. The company also announced the Earning Per share of Rs. 9.55 which was Rs. 10.23 for the last corresponding same year.
Furthermore, the Net Sales/Revenue of the company were slightly increased by 8% to Rs. 36.5 Bn from the last year sales. The company Gross Profit also declined to Rs. 7.71 Bn from the last year.
Whereas, the Other income of the company was increased by 35% to Rs. 1.99 Bn YoY basis.
However, the Finance cost of the company was massively increased by 96% and recorded at 289.6 Mn during the corresponding year, which was Rs. 147.3 Mn in the last year.
The company also announced the Final Cash Dividend of Rs. 6 per share i.e. 60%.
GALXO – Annual Result
EPS 2019 = 9.55 PKR
EPS 2018 = 10.23 PKR
Cash Dividend = 6.00 PKR (60%)
Bonus Share = NIL